Acuity Inc. has already reported first-quarter fiscal 2026 results, with sales rising to US$1,143.7 million and net income ...
Detailed price information for Capital Clean Energy Carriers Corp (CCEC-Q) from The Globe and Mail including charting and trades.
Delivered Net Sales of $1.1B, an Increase of 20% Compared to the Prior YearDelivered Operating Profit of $160M, Up 20% Compared to the Prior Year; Grew Adjusted Operating Profit to $196M, Up 24% Compa ...
Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...
Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
BACKGROUND/AIMS The advantages of logMAR acuity data over the Snellen fraction are well known, and yet existing logMAR charts have not been adopted into routine ophthalmic clinical use. As this may be ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback